<DOC>
	<DOCNO>NCT01096875</DOCNO>
	<brief_summary>Experimental data demonstrate favourable effect statins endothelial progenitor cell ( EPC ) mobilization bone marrow , cardiac homing . The purpose present prospective randomize control trial determine effect aggressive atorvastatin treatment ( 40 mg daily 2-weeks prior surgery ) number endothelial progenitor cell ( EPCs ) cardiopulmonary bypass compare placebo .</brief_summary>
	<brief_title>Effects Atorvastatin Endothelial Progenitor Cells After Coronary Surgery</brief_title>
	<detailed_description>Endothelial progenitor cell , subgroup hematopoietic stem cell significant role vascular homeostasis . In animal model ischemia , endothelial progenitor cell rapidly incorporate site neovascularization , potential induce augment vasculogenesis/ angiogenesis , prevent cardiomyocyte apoptosis peri-infarct region , reduce adverse remodeling . Treatment atorvastatin show increase endothelial progenitor cell count patient coronary artery disease . Therefore , investigate whether atorvastatin augments number endothelial progenitor cell cardiopulmonary bypass patient undergoing coronary artery bypass surgery ( CABG ) . Thus , conduct randomized double-blind , placebo-controlled , 2-way parallel trial 60 patient undergoing coronary artery bypass surgery . Patients receive either 2-week treatment atorvastatin placebo prior surgery . Endothelial progenitor cell quantitated flow cytometric phenotyping obtain peripheral blood sample . In addition , cardiac marker ( CK-MB mass , cardiac troponin-I ) , biochemical profile , liver function test , high sensitive C-reactive protein ( hsCRP ) coagulation profile determine 4 time point : 1 ) preoperatively ( baseline ) ; 2 ) 6 hour end cardiopulmonary bypass ; 3 ) 24 hour surgery ; 4 ) 5th day postoperatively . Clinical , operative characteristic , cardiac marker , high sensitive C-reactive protein endothelial progenitor cell count compare group . Adverse outcomes also note report .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patients undergo elective isolated coronary artery bypass surgery onpump technique Written inform consent Concomitant valve aortic surgery Left ventricular aneurysm repair Reoperation Emergency surgery History myocardial infarction within less 4 week Hepatic impairment Chronic renal impairment Drug related side effect ( allergy hypersensitivity ) Familial Hyperlipidemia Autoimmune condition require steroid</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Endothelial progenitor cell</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Coronary surgery</keyword>
</DOC>